Brown Financial Advisory’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$784K Sell
2,996
-307
-9% -$78.7K 0.33% 19
2026
Q2
$831K Sell
3,303
-419
-11% -$90.1K 0.35% 17
2026
Q1
$810K Buy
3,722
+9
+0.2% +$2K 0.4% 18
2025
Q4
$848K Hold
3,713
– – 0.43% 17
2025
Q3
$860K Hold
3,713
– – 0.45% 18
2025
Q2
$689K Buy
3,713
+662
+22% +$123K 0.38% 22
2025
Q1
$639K Buy
3,051
+1,131
+59% +$220K 0.4% 21
2024
Q4
$341K Buy
1,920
+155
+9% +$28.5K 0.24% 24
2024
Q3
$349K Hold
1,765
– – 0.25% 22
2024
Q2
$303K Hold
1,765
– – 0.23% 24
2024
Q1
$321K Sell
1,765
-39
-2% -$6.72K 0.25% 23
2023
Q4
$280K Hold
1,804
– – 0.23% 24
2023
Q3
$269K Hold
1,804
– – 0.24% 23
2023
Q2
$243K Hold
1,804
– – 0.2% 27
2023
Q1
$288K Hold
1,804
– – 0.28% 23
2022
Q4
$292K Hold
1,804
– – 0.3% 22
2022
Q3
$242K Buy
+1,804
New +$259K 0.23% 25

Other funds holding ABBV

Brown Financial Advisory's ABBV Position: Q3 2026 in Review

Brown Financial Advisory reduced its AbbVie (ABBV) stake by 9.3% in Q3 2026, selling an estimated $78.7K and leaving 2,996 shares worth $784K. The position accounts for 0.33% of the portfolio, ranked #19.

Brown Financial Advisory first reported a position in ABBV in Q3 2022 and has held it in 17 quarters since. The position peaked at $860K in Q3 2025. 2,964 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • Brown Financial Advisory held 2,996 shares of AbbVie worth $784K as of Q3 2026.
  • Brown Financial Advisory sold 307 AbbVie shares in Q3 2026, an estimated $78.7K.
  • AbbVie made up 0.33% of Brown Financial Advisory's portfolio in Q3 2026, its #19 holding.
  • Brown Financial Advisory first reported a position in AbbVie in Q3 2022 and has held it in 17 quarters since.
  • Brown Financial Advisory's AbbVie position peaked at $860K in Q3 2025.
  • 2,964 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on Brown Financial Advisory's 13F filing for Q3 2026, filed 5 Nov 2026.